Clinical Trial Update: Dietary and Dialysate Sodium Reduction on Body Fluid Volume and Inflammatory State in Hemodialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of dietary sodium and dialysate sodium reduction on body fluid volume and inflammatory state in hemodialysis patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Stage
• End-stage Renal Disease

Snippet

Sponsor: UPECLIN HC FM Botucatu Unesp | Conditions: Chronic Kidney Diseases Stage 5 | Phase 4 | Status: COMPLETED